TUROKTOKOG ALFA PEGOL medicinal products
Original notice title
Czechia – Pharmaceutical products – Léčivé přípravky s účinnou látkou TUROKTOKOG ALFA PEGOL
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Fakultní nemocnice Brno
- Country
- Czech Republic
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Dec 01, 2026
- Estimated value
- CZK 34.3M (approx. EUR 1.4M)
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Award Criteria
Lot 1
Buyer
Location
Brno, CZE
Website
Buyer profile
Identifier
65269705
Activity
Health
Lots (1)
LOT-0001
Léčivé přípravky s účinnou látkou TUROKTOKOG ALFA PEGOL
Předmětem zadávacího řízení je uzavření kupní smlouvy na dodávky léčivých přípravků (dále také „zboží“) dle skutečných potřeb zadavatele.
EUR 1.4M
Estimated value
Location
Duration
Category
Award Criteria
Award details
ekonomicky nejvýhodnější nabídka
Procurement Details
- Publication date
- 01 Nov 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 760112-2026
Documents (1)
Similar tenders
Poland – Pharmaceutical products – 149/PN/ZP/D/2026 - Dostawa produktów farmaceutycznych do programów lekowych
Croatia – Pharmaceutical products – Ostali lijekovi (koji nisu uključeni u kategorije pod rednim brojem 1 i 17) - XXIII - za zdravstvene ustanove u Republici Hrvatskoj
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)
Croatia – Pharmaceutical products – Ostali lijekovi (koji nisu uključeni u kategorije pod rednim brojem 1. i 17.) - XXII - za zdravstvene ustanove u Republici Hrvatskoj
Germany – Pharmaceutical products – 1/DLII6/VM131 - RV div. Arzneimittel
France – Pharmaceutical products – MARCHE UNICANCER DE LA FOURNITURE ET LIVRAISON DE MEDICAMENTS CUH (CONDITIONNEMENT UNITAIRE HOSPITALIER) ET INJECTABLES
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications